Quick Facts at a Glance
- Recall Date
- January 21, 2026
- Hazard Level
- HIGH
- Brands
- DOXAZOSIN MESYLATE, Unichem Pharmaceuticals (USA), Inc.
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- DOXAZOSIN MESYLATE, Unichem Pharmaceuticals (USA), Inc.
- Product type
- Doxazosin Tablets
- Model numbers
- Lot # GDSH25006, Exp Date: 08/2027
- UPC codes
- 29300-351, 29300-352, 29300-353, 29300-354, 29300-351-13, 29300-351-01, 29300-351-10, 29300-352-13 +6 more
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
January 21, 2026
Reported by FDA DRUG
February 18, 2026
RecallRadar source check
February 25, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Tablets/Capsules Imprinted with Wrong ID
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
Doxazosin Tablets are prescribed primarily for managing high blood pressure and symptoms of BPH. Patients often rely on these medications for effective treatment.
Why This Is Dangerous
The recall was initiated because the tablets were imprinted with incorrect identification. This could lead to confusion and potential misuse by patients.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks if they continue using the recalled product. The need to consult healthcare providers and seek alternatives may cause delays in treatment.
Practical Guidance
How to identify if yours is affected
- Check the lot number on your bottle.
- Verify the expiration date.
- Confirm with your pharmacy if needed.
Where to find product info
The lot number can typically be found on the label of the bottle, along with the expiration date.
What timeline to expect
Expect a refund or replacement process to take approximately 4-6 weeks.
If the manufacturer is unresponsive
- Document your communications with Unichem Pharmaceuticals.
- Follow up via phone or email if no response is received within a week.
- Consider filing a complaint with the FDA if issues persist.
How to prevent similar issues
- Always check for recalls on medications before use.
- Keep all medication labels and packaging for reference.
- Consult with healthcare providers regularly about your prescriptions.
Documentation advice
Keep records of your purchase receipt, any correspondence with the company, and photographs of the product.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recall involves Doxazosin Tablets, USP, 4 mg, sold in 1000-tablet bottles. The affected lot is GDSH25006, with an expiration date of August 2027. These tablets were distributed nationwide.
Key Facts
- Imprinted with wrong ID
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
